(IBRN) iShares Trust - iShares - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3532 • Health
IBRN: Pharmaceutical, Biotechnology, Healthcare
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
Additional Sources for IBRN ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBRN ETF Overview
| Market Cap in USD | 4m |
| Category | Health |
| TER | 0.47% |
| IPO / Inception | 2022-08-24 |
IBRN ETF Ratings
| Growth 5y | 13.3% |
| Fundamental | - |
| Dividend | 33.3% |
| Rel. Strength Industry | -101 |
| Analysts | - |
| Fair Price Momentum | 23.24 USD |
| Fair Price DCF | - |
IBRN Dividends
| Dividend Yield 12m | 0.39% |
| Yield on Cost 5y | 0.41% |
| Annual Growth 5y | 168.59% |
| Payout Consistency | 66.7% |
IBRN Growth Ratios
| Growth Correlation 3m | -77.7% |
| Growth Correlation 12m | 36.8% |
| Growth Correlation 5y | 12.7% |
| CAGR 5y | 2.24% |
| CAGR/Mean DD 5y | 0.23 |
| Sharpe Ratio 12m | -0.09 |
| Alpha | -26.88 |
| Beta | 1.01 |
| Volatility | 22.12% |
| Current Volume | 0.2k |
| Average Volume 20d | 1.1k |
What is the price of IBRN stocks?
As of January 23, 2025, the stock is trading at USD 25.80 with a total of 180 shares traded.
Over the past week, the price has changed by +1.89%, over one month by +0.35%, over three months by -4.79% and over the past year by -0.23%.
As of January 23, 2025, the stock is trading at USD 25.80 with a total of 180 shares traded.
Over the past week, the price has changed by +1.89%, over one month by +0.35%, over three months by -4.79% and over the past year by -0.23%.
Is iShares Trust - iShares a good stock to buy?
Neither. Based on ValueRay Analyses, iShares Trust - iShares is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 13.31 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBRN as of January 2025 is 23.24. This means that IBRN is currently overvalued and has a potential downside of -9.92%.
Neither. Based on ValueRay Analyses, iShares Trust - iShares is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 13.31 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBRN as of January 2025 is 23.24. This means that IBRN is currently overvalued and has a potential downside of -9.92%.
Is IBRN a buy, sell or hold?
iShares Trust - iShares has no consensus analysts rating.
iShares Trust - iShares has no consensus analysts rating.
What are the forecast for IBRN stock price target?
According to ValueRays Forecast Model, IBRN iShares Trust - iShares will be worth about 25.9 in January 2026. The stock is currently trading at 25.80. This means that the stock has a potential upside of +0.19%.
According to ValueRays Forecast Model, IBRN iShares Trust - iShares will be worth about 25.9 in January 2026. The stock is currently trading at 25.80. This means that the stock has a potential upside of +0.19%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.9 | 0.2% |